ELV

NYSEElevance Health Inc
High Tide · 55Squeeze · Idle 18Neutral0 buys · $0Social · Quiet 14
$402.86
+$3.99 (+1.00%)
15-min delayed · Aug 26, 11:40 AMReal-time

Score summary

Buy
Analyst Ratings
20Ratings
14 Buy6 Hold0 Sell
Tide Score
55
High Tide · stable · Top 40% of universe (3876)
Outlook56High Tide · stable · Top 40% of universe (3876)
Squeeze Score
18
Idle ·
  • Days to cover3.93
  • Short interest2.66% of float
  • Borrow rate27.99%
  • Short interest trend-0.20% (30d)
Trend
Neutral
No clear trend (signals split)
Recent Smart Money
0 buys
Quiet · $0 · 14d · 5 super investors

Key statistics

Market Cap
$86.86B
52-week range
$279.02 – $426.79
43% from low
Day range
$398 – $403
Open $402.67
Volume
933k
vs 1.3M avg · 72%
P/E (TTM)
17.7
Fwd 13.5
Earnings
Oct 21
56d · est $4.66

Country ranks

US RankCountry rank populator pending
BW universe: US & CA common stocks only · ETFs and mutual funds excluded · Methodology →

Price chart with forecast cone and smart-money events

Wall Street Analyst Consensus

Wall Street Analyst Consensus
Aggregate of 20 third-party analyst opinions — not Quantellect advice.
12-mo median price target
$456
20 Wall St 12-month targets
High
$498
Average
$438
Low
$343
$272$331$389$448$507HIGH$498MEDIAN$456LOW$343Feb ’26NOW12-mo target
Recent price history, then Wall-Street analysts’ 12-month price targets (high / median / low) shown forward to the 12-month target levels. Targets are third-party analysts’ estimates of future performance — not guarantees, and not Quantellect recommendations. Past results do not guarantee future returns.
Per-analyst ratings are not yet available for this ticker.
Aggregate of third-party analysts’ published opinions, shown for information only — not Quantellect advice. The 68/100 Analyst Score (Buy) is Quantellect’ documented weighting of the rating distribution on the same 0–100 scale as the Tide / Squeeze / Trend / Money scores; the verdict label is derived from that score. Past results do not guarantee future returns. Source: aes.

Why Tide score breakdown

Smart-money feed

Social pulse

Smart-money modules

Catalysts ahead

Catalysts aheadEarnings Oct 21 (post-market, est EPS $4.66) · Annual shareholder meeting Jun 17 · Russell 1000 rebalance Jul 22 · DOJ CUDA hearing window Q3

Drill deeper

Not investment advice. Past results do not guarantee future returns. Scores, narratives, and historical-cohort statistics on this page are generated by Quantellect algorithms from public filings, market data, and AI synthesis, and describe the historical performance of structurally similar setups in our universe; failures are included. Data may be 15-minute delayed, contain errors, or be revised. Always do your own research and consult a licensed financial advisor before making investment decisions.